Lv et al. also revealed that sulforaphane (SF) can delay retinal photoreceptor cell degeneration in diabetes via inhibition of endoplasmic reticulum stress (ERS), inflammation, and TXNIP expression through AMPK pathway activation [8]. Here, TXNIP is linked to diabetes mellitus.